Literature DB >> 12763218

Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors.

H Paganini1, V Staffolani, P Zubizarreta, L Casimir, H Lopardo, V Luppino.   

Abstract

Viridans streptococci (VS) are an increasing cause of bacteraemia in neutropenic patients with cancer. Case-control studies of predisposing factors for acquisition of this infection in children are not published. Between January 1989 and December 1999, 168 episodes of bacteraemia in 161 children with fever and neutropenia of haemato-oncology origin were analysed. 15 cases (9%) in 15 patients were caused by VS. Each case patient was compared with 6 matched control patients; 2 with other Gram-positive cocci (group 2), 2 with gram-negative bacilli bacteraemia (group 3) and two children with fever and neutropenia without bacteraemia (group 4). The median age of patients was 4.1 years (range: 2-15 years). 87% of children had acute leukaemia or lymphomas. Pneumonia was the predominant clinical focus (70%). Shock was observed in 13% of patients. ARDS was observed in one child who died of this complication. Multivariate analysis of risk factors for the development of VS bacteraemia showed that two factors were independent predictors: high doses of cytosine-arabinoside (ARA-C) as part of the chemotherapy treatment (Odds Ratio (OR): 9.3; Confidence Interval (CI) 1.56-55.5) (P<0.014) and the presence of pneumonia (OR: 1.36: CI 2.27-81.9) (P<0.0043). We propose that further studies are warranted to confirm these results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763218     DOI: 10.1016/s0959-8049(03)00272-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases.

Authors:  Xiang Y Han; Mallika Kamana; Kenneth V I Rolston
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Etiology and clinical course of febrile neutropenia in children with cancer.

Authors:  Hana Hakim; Patricia M Flynn; Katherine M Knapp; Deo Kumar Srivastava; Aditya H Gaur
Journal:  J Pediatr Hematol Oncol       Date:  2009-09       Impact factor: 1.289

3.  Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia.

Authors:  S B Han; E Y Bae; J W Lee; D G Lee; N G Chung; D C Jeong; B Cho; J H Kang; H K Kim
Journal:  Infection       Date:  2013-05-03       Impact factor: 3.553

4.  [Requirements for hygiene in the medical care of immunocompromised patients. Recommendations from the Committee for Hospital Hygiene and Infection Prevention at the Robert Koch Institute (RKI)].

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2010-04       Impact factor: 1.513

5.  Risk Factors for Viridans Group Streptococcal Bacteremia in Neutropenic and Non-neutropenic Patients: A Single Center Case-Case-Control Study.

Authors:  Augusto Dulanto Chiang; Ninet Sinaii; Tara N Palmore
Journal:  Open Forum Infect Dis       Date:  2017-12-02       Impact factor: 3.835

6.  Evaluation of Empiric Vancomycin for Fevers During High-dose Cytarabine Administration.

Authors:  Alex Hoover; Jessica A O Zimmerman; Sawyer Wiese; Arunkumar Modi
Journal:  J Pediatr Hematol Oncol       Date:  2021-10-01       Impact factor: 1.170

7.  Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.

Authors:  Maryke J Nielsen; Sarah Claxton; Barry Pizer; Steven Lane; Richard P D Cooke; Stéphane Paulus; Enitan D Carrol
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 8.  Febrile neutropenia in children with cancer.

Authors:  Stéphane Paulus; Simon Dobson
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.